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A series of anti, anti-dichloro-N-substituted
azaadaman-
tanes have been synthesized (Henkel et al, 1981, J. Org. Chem. , 46,
3483) representing conformationally rigid nitrogen mustards incor
porated into an adamantyl framework with well defined stereochemistry
and fixed separation distances between alkylating centers of 3.6 A
(1) and 2.5 X (2,3) (Henkel et al, 1981, J. Org. Chem., 46, 3483) to
be used as structurally rigid probes of DNA alkylation and
intermo-









R = CH3; CH2CH2N(C5H1Q)
The aqueous solution stability and the extent of intermolecular DNA
crosslink formation for both the N-methyl and N-piperdinoethyl series
of isomers have been measured using novel modifications of an
ethidi-
um bromide fluorescence assay technique. Results indicate that
isomers 1 and 2 of both series form intermolecular crosslinks to an
appreciable extent, while little or no crosslinking is observed under
similar conditions for isomer 3 of both series. Analysis of the
aqueous solution stability, time dependent crosslinking reaction
isotherms and crosslink stability indicate significant
differences
both within and between series, which suggests stereospecific
cross-
linking behavior at the molecular level.
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GENERAL INTRODUCTION
REVIEW OF DNA CROSSLINKING, EXAMPLES OF CROSSLINKING AGENTS
AND METHODS OF DNA CROSSLINKING ANALYSIS
MOLECULAR CROSSLINKING OF DNA
It is important to note that in the Watson and Crick model of
DNA, there exists no covalent bonds between either bases on the same
nucleic strand or between bases on opposing nucleic strands. There
are, however, a large number of bifunctional alkylating agents
capable of forming such covalent bonds. These introduced bonds,
referred to as crosslinks, can take two different forms; intrastrand
crosslinks and interstrand crosslinks as shown.
Intrastrand Interstrand Interstrand
Figure 1. Intrastrand and interstrand crosslinking.
An intrastrand crosslink occurs by alkylation of two of the
nucleic acid bases located on the same DNA strand. Intrastrand
crosslinks, as well as monoalkylation of bases by monofunctional
alkylating agents may have serious consequences on normal DNA repli
cation and cell proliferation (Eastman, 1981) . However ; many of
these types of crosslinks have also been shown to be easily repaired
in vivo prior to DNA replication (Joshua et al, 1980).
Interstrand crosslinks occur by alkylation of two nucleic acid
bases on opposite DNA strands. These bases may be a complementary
base pair or unassociated bases within the reaction distance of the
alkylating agent. This type of crosslink formation has a significant
effect on the cycle of normal DNA replication and transcription, and
has been shown to correlate well with cell cytotoxicity (Lown, 1979).
Because of this correlation, the rest of the discussion will focus on
the formation of interstrand crosslinks.
BIOLOGICAL EFFECTS OF CROSSLINKING
It has previously been shown that the introduction of just one
crosslink is sufficient to prevent complete strand separation of the
entire DNA molecule (Kohn et al, 1966; Geduschak, 1961). Such
crosslinks would therefore be expected to inhibit DNA replication and
transcription, in which strand separation is a necessary step.
Previous studies have established direct correlations between
the efficiency of DNA crosslinking by various alkylating agents, such
as mitomycin C and some aziridinoquinones, and anti-leukemic activity
(Akthar et al, 1975; Lown, 1979). These helped to explain earlier
observations that potent tumor inhibition of alkylating agents
occurred only with compounds having at least two functional groups
(Haddow et al, 1948; Loveless, 1951). It is now well accepted that
the formation of DNA interstrand crosslinks is the primary cytotoxic
event associated with the observed anti-leukemic activity, and that
the measurement of DNA crosslinking may be a useful method for the
pre-screening of potential anti-leukemic drugs (Conners, 1974).
Generally, the crosslinks formed may be repaired by nuclear
repair enzymes if enough time is available before the S phase of DNA
replication is reached. If insufficient time is allowed for repair,
lethality results due to the inhibition of DNA replication. There
fore, it can be seen that the crosslinking event is not immediately a
lethal event itself, but causes cell death only if the timing of the
cycle is right. Hence, due to the rapid replication cycle of cancer
ous cells, interstrand crosslink formation exhibits good anti-leuke
mic activity (Skipper, 1971). Because of this, many of the anti
cancer chemotherapeutic drugs used today are crosslinking agents.
EXAMPLES OF CROSSLINKING AND CROSSLINKING AGENTS
A. Thymine Dimer Intrastrand Crosslinking:
The most common example of crosslinking is the formation of
thymine dimers. These dimers are natural, ultraviolet induced,
intrastrand crosslinks between adjacent prymidine bases requiring no
alkylating agent. The dimers generally result in the formation of
cyclobutane type dimers between adjacent thymines, although this type
of dimer also forms between adjacent cytosines or between a thvmine
and an adjacent cytosine, but to a much lesser extent. The dimers






Figure 2. Structure of thymine dimer.
The formation of thymine dimers is not such a problem today as
in the early development of life on earth. Today, the ozone in the
earth's atmosphere screens out essentially all sunlight wavelengths
less than 300 nm. , and short wavelengths are the most damaging as the
absorption of pyrimidine bases peaks near 260 nm. However, even
sunlight in the 300 to 350 nm. range can be damaging, so cells have
developed two types of repair mechanisms for the lesions caused by
ultraviolet light. The first of these is an excision repair mecha
nism involving the removal of the mutated bases by an exonuclease,
the replacement of these bases by DNA polymerase activity and the
backbone of the DNA completed by DNA ligase.
The second, and more common, repair mechanism is that bv an
enzymatic photoreactivation by a photoreacting enzyme that uses the
energy of light to decompose the dimers. The enzyme responsible for
this activity in E. Coli. has been purified and has been found to
bind specifically to DNA containing cyclobutane type dimers, forming
a complex that absorbs maximally near 350 nm. When the complex is
irradiated in this wavelength region, the dimers separate into their




















Figure 4. Enzymatic photoreactivation of thymine dimers,
Unrepaired cyclobutane pyrimidine dimers induced in DNA bv ul
traviolet light are known to have lethal, mutagenic and tomourisenic
effects (Setlow, 1966; 1968; Meistrich, 1972; Hart et al, 1977).
It is also likely that these dimers make a significant contribution
to the incidence of skin cancer, which results largely from
overexposure to solar ultraviolet light (Blum, 1959; Urbach, 1975;
Black and Chan, 1977). Most of the carcinogenic effects of solar
ultraviolet radiation probably arise from exposure to wavelengths of
295 to 315 nm. , since, as previously stated, shorter wavelengths are
filtered out by atmospheric ozone and longer wavelength (>310 nm.),
despite their higher flux, have less biological effect (Setlow,
1974).
B. Interstrand Crosslinking by Bifunctional Alkylating Agents:
With respect to alkylation by bifunctional alkylating agents,
the compounds can be divided into two main categories; those called
"direct"
because they are reactive with DNA without enzymatic activa




A well known group of naturally occurring substances which act
as direct alkylating agents are the psoralens, also known as
furocou-
marins, which exhibit strong photosensitizing properties by irradi
ation with near ultraviolet light (320 to 380 nm) . Many psoralen
derivatives have also been synthesized, for example the 4,5',8-tri-
methylpsoralen, and some of these are the most potent photosensiti
zing substances in the group (Musajo and Rodighiero, 1970).
The psoralens are used clinically to treat skin pigmentation
disorders and to increase tolerance of sensitive skin to light (Cole,
Figure 5. Structure of psoralen (I) and
4,5'
,8-trimethylpsoralen (II).
1970) . These compounds photoreact directly with biological
macromo-
lecules, primarily DNA and to a lesser extent RNA and proteins
(Pathak and Kramer, 1969; Musajo et al, 1966).
Although the mechanism of action of these compounds is not known
for sure, the best evidence to date points to the formation of two
cycloadditions between neighboring pyrimidines on opposite strands.
Reactions carried out with psoralen and several of its derivatives
with unsaturated ketones show photodimerizations and photochemical
adducts of two types. Some of the reactions produced cyclodimers and
cycloadducts via the C3-C4 double bond of the psoralens, whereas
other photoaddition reactions resulted in cycloadducts involving the
C4'-C5'
double bonds (Vessely and Kotlan, 1955; Krauch and Farid,
1967) . Reactions between pyrimidine bases and psoralens indicated
the formation of cycloadducts of the two with the pyrimidine bases
reacting with their 5,6 double bond while the psoralens react either




The photochemical reaction of psoralens with DNA involves the
formation of covalent interstrand crosslinks (Lown and Sim, 1978) .
In DNA, however, stereochemical considerations and the known distance
y ch3
^^
Figure 6. Photoreaction products of psoralen with thymine
of the reaction sites of the psoralens limit the number of geometric
configurations which could easily lead to a crosslink. Ronald S.
Cole assembled a number of relative configurations, examining between
probable reactive sites and found that a psoralen intercalated in the
stacked bases of a DNA duplex could overlap two bases to form the
observed crosslinks . There were at least two configurations where a
psoralen that is intercalated between the stacked bases has its two
photochemically reactive positions aligned with the 5,6 double bond
of two neighboring pyrimidines on opposite strands.
Figure 7. Intercalated reactive position of psoralen.
The base pairs containing the pyrimidines are rotated
24
because of the intercalation rather than the normal 36. The psora
len reaction sites and the 5,6 pyrimidine double bonds are adjacent
and have relative orientations which could lead to the formation of a
crosslinking adduct (Cole, 1970).
The major advantage of these compounds is their ability to
penetrate cells and viruses in vivo with no apparent disruption of
cellular processes in the absence of photoexitation (Wiesehahn et al,
1977) . They show a high specificity for DNA compared with proteins
and form stable interstrand crosslinks with a high reaction efficien
cy without the accompanying degradation of DNA that is found with
other crosslinking agents such as mitomycin C (Lown, 1979; Cech and
Pardue, 1976; Hatchard and Parker, 1956).
2. Mitomycin C:
The mitomycin antibiotics were first isolated by Hata in Japan
from Streptomyces caespitosus (Hata et al, 1956). Of these, mitomy
cin C has been the most thoroughly studied of the group and has been
found to be effective against a range of neoplasms. Therefore,
mitomycin C is clinically used today for the treatment of carcinomas
of the breast, lungs, colon and stomach (Lown, 1979; Szybalski and
Iyer, 1967).
Figure 8. Structure of mitomycin C.
Earlier studies by Szybalski and Iyer (1967) on the mechanism of
action established that DNA is the principle target of mitomycin C
and predicted three possible reactive sites by which it exhibited its





Figure 9. Enzymatic activation of mitomycin C.
An enzymatic reduction activation produces the hydroquinone which in
turn loses methanol to give the active aziridinomitosene.
Mitomycin C has been shown to crosslink DNA (Kirsch, 1967) .
Although the exact mechanism of action has not, as of yet, been
thoroughly worked out, studies by Lown (1979) and Tomasz (197^) have
shown that the drug does not alkylate the N7 of guanine, a common
reactive site for a variety of alkylating agents (Lawley, 1966).
Lown has therefore postulated that the alkylation probably takes
place at the 06 of guanine (Lovn, 1979).
Besides the formation of interstrand crosslinks with DNA,
mitomycin C has also been observed to degrade DNA in vivo (Reich et
al, 1960; Wakaki, 1961) which had previously been attributed to the
stimulation of exonucleases in the repair cycle (Kersten, 1Q62;
Nakata et al, 1961). However, it has since been demonstrated that
the mitomycins actually inhibit nuclease activity (Goodr.nn el al,
1974) . Lown (1979) , using covalently closed circular DNA and selec
tive enzymatic and chemical inhibitors, proposed another r.echanisr. of
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DNA strand scission by mitomycin C in vivo. Through a series of
metabolic steps, a hydroxyl radical is formed which has been shown to
degrade DNA through a series of reactions involving initial hydrogen
extraction from C4 of the ribose (Dizdaroglu et al, 1975). This DNA
strand scission is a very important feature, as it is an irreversible
event and should prove even more lethal to the cell than interstrand
crosslinking.
3. Nitrosoureas:
During the routine screening of compounds for activity against
murine leukemia L1210 for the Cancer Chemotherapy National Science
Center in 1959, it was found that
N-methyl-N'-nitro-N-nitrosoguani-
dine (MNNg) was somewhat active. This began an investigation of
nitrosoureas at the Southern Research Institute and of nitrosoguani-
dines at the Stanford Research Center (Skinner et al, 1960; Hyde et
al, 1962) . Soon it was discovered that replacement of the methyl
group on the nitrosated N atom for each series of compounds with a
2-haloethyl group gave increased anti-leukemic activity and that the
nitrosoureas showed greater activity than the nitrosoguanidines
(Wheeler, 1976). Further studies on nitrosoureas led to the conclu
sion that even greater activity was obtained when the substituent on
Nl was a 2-chloroethyl or a 2-fluoroethyl and the substituent on N3
was a 2-chloroethyl, 2-fluoroethyl, cycloaliphatic or a heteroalicyc-
lic group (Johnston et al, 1966, 1971).
Unlike most of the previous anti-cancer agents, it was found
that intraperitoneally administered N-methyl-N-nitrosourea (MNU) was
active against intracerebrally inocculated L1210 cells (Skipper et
11
al, 1961) . This aspect of the nitrosoureas is important and will be
discussed in further detail in a later section.
The three disubstituted nitrosoureas shown (Figure 10) are
currently undergoing extensive clinical trials.
? ff
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Figure 10. Structures of BCNU, CCNU and MeCCNU.
Nitrosoureas like BCNU decompose under physiological conditions
without enzymatic activation to give rise to isocyanates and
2-halo-
ethyl cationic species and the latter alkylate and crosslink DNA to
give the observed biological effects (Ludlum and Tong, 1981).
The crosslink occurring in halonitrosourea-treated mammalian
cells has not, as yet, been isolated or characterized. It has,
however, been suggested to consist of an ethylene bridged crosslink
between the 06 of guanine and the N4 of cytosine as shown (Ton et al,
1982).
The proposed mechanism involves a chloroethyl carbonium ion























Figure 11. Mode of decomposition of nitrosoureas.
deoxyguanosine. This derivative then rearranges and subsequently
alkylates the opposite nucleotide to form the interstrand crosslink.
4. Nitrogen Mustards:
One of the earliest bifunctional alkylating agents studied, of
which a substantial body of knowledge is known, is the nitrogen
mustards, the prototype of which is mechlorethamine (HN2) .
HN2 has been found to produce covalent crosslinks between the
paired strands of a DNA duplex (Geiduschek, 1961; Brookes and Lawley,











Figure 12. Possible route to formation of crosslink.
CH,
Cl-CH -CH -N-CH -CH -CI
Figure 13. Structure of mechlorethamine,
1A
forming a transition complex with the nucleophile, with the kinetics
of the alkylation therefore being bimolecular (Lawley, 1966) .
The two step process involves an initial activation through an
anchimeric effect of the nitrogen to yield an aziridinium intermedi
ate. Alkylation by a nucleophile forms the initial covalent link,
after which a second activation and alkylation step establishes a
5-atom crosslink to one of the neighboring nucleophilic centers
(Henkel, 1983).
The distance over which the crosslink occurs has been estimated
(by the use of Dreiding models) using the second activated intermedi
ate, and has been found to be ca. 4.5-5.0 A away from the alkylated
nucleophile on the other arm. Although it is possible for the
molecule to assume other conformations in which the reaction dis
tances are less (2.5-3.0 A), these conformations would be highly
disfavored due to the presence of severe gauche interactions (Henkel,
1983).
Brookes and Lawley identified a reaction product of HN2 with DNA
consisting of an HN2 moiety bound to two guanine residues and sug
gested that the interstrand crosslink occurs between two guanines.
They later identified the major site of alkylation on the bases on
bihelical DNA as being the N7 of guanine (Brookes and Lawley, 1961;
Kohn et al, 1966) .
Although the exact site of DNA alkylation by HN has not been
unequivically determined, examinations of space filling models by
Kohn (1966) have indicated that an HN2 crosslink could possibly occur
between two guanine N7 positions on opposite strands, requiring a




















Figure 14. Two step mechanism of mechlorethamine .
then lie in the major groove of the DNA duplex connecting guanines of
adjacent base pairs. The base sequence required for this type of
crosslink must therefore be G(3'-5')C, as the sequence C(3'-5')G does
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not allow this type of crosslink formation (Kohn et al, 1966). Kohn
also found that a large majority of DNA alkylations by HN2 do not
result in interstrand crosslink formation, and that only one cross
link was produced per approximately 25 HN2 alkylations. Alkylation
without crosslink formation may occur when the initial binding is at
a site from which no second alkylation site on the opposite DNA
strand can be reached, or when hydrolysis or reaction with other
available nucleophiles in the solution intervenes (Kohn et al, 1966).
Reactions of HN2 with DNA have shown a large decrease in the
apparent molecular weight of the DNA at in vitro physiological
conditions of 37C and pH=7 (Butler et al, 1952), with the kinetics
of this apparent decrease increasing at acidic conditions (Lawley,
1957) . It has also been previously shown that HN2 crosslinked DNA is
stable in alkaline conditions over a very wide temperature range
(Kohn et al, 1966). DNA methylation experiments indicated that N7
methylated guanines on DNA result in the loss of 7-methyl guanine by
hydrolysis of the 7-alkyl guanine deoxyriboside linkage leading to
guanine ring cleavage at acidic or in vitro physiological conditions
(Lawley, 1957) . At alkaline pH, N7 methylated guanines undergo base
catalyzed ring opening of the guanines with the 7-alkyl guanine
deoxyriboside linkage remaining intact (Townsend and Robbins, 1962).
These findings account for the acidic and neutral instability and




Gel electrophoresis of DNAs generally involves the cutting of
the DNA with restriction endonucleases and analyzing the fragments to
establish an internally consistent set of molecular weights. A
horizontal gel system with agarose or polyacrylamide gels is usually
used, with the gels at very low concentrations so they do not distort
during electrophoresis and, therefore accurate relative mobilities of
large DNA's are obtained. Excellent resolution can be gained for
DNA's of molecular weights up to at least 26.5 X 105, a difference of
less than 10% being readily resolved even for molecules of this size.
In both neutral and alkaline gels, the relative mobilities of DNA's
shorter than about 1000 base pairs (or bases) are essentially insen
sitive to voltage gradients commonly employed (1-5 V/cm.). The
larger the DNA, however, the more sensitive the relative mobilities
become to the voltage gradient, with DNAs longer than about 20,000
base pairs (or bases) being severely affected. This is most likely
due to the distortion of the DNA equilibrium conformations allowing
the molecule to enter and penetrate channels in the gel that would
normally exclude them in their undisturbed conformations. Thus, low
voltage gradients are necessary for the separations of large DNAs
(McDonnel et al, 1976).
In the analysis of psoralen crosslinked DNA in neutral and
agarose gels (Cech, 1981), it is noted that the electrophoretic
mobility of the various extents of crosslinked DNA differ for each
gel. In the example shown, electrophoresis of
4,5'
,8-trimethylpsor-
alen crosslinked 0X174 Hae III fragments was conducted on neutral and
alkaline agarose gels. The electrophoresis was carried out for 12-14
hours at 100 mA constant current (50 V) and the gels were then
18
stained with ethidium bromide and illuminated by a 300 nm. radiation
source. The alkaline gels were at a sufficient pH (12.4) to ensure
denaturation of the DNA.
(a) 0 07 1.3 6 25 CO
OR''
(b) 0 0.7 1.3 6 25 CO OX
OR-I
Figure 15. Electrophoresis of crosslinked DNA in neutral and
alkaline agarose gels. Capital letters indicate Hae III fragments.
(CO)DNA exposed neither to drug nor radiation. The samples were
electrophoresed on (a) a neutral agarose 1.4% agarose gel and (b) an
alkaline 1.4% agarose gel. (OR) Origin. Numbers on top indicate
time of irradiation in presence of drug (min.).
Electrophoresis, in both neutral and alkaline gels, of DNA
mixtures irradiated in the absence of drug and DNA with drug that
19
were kept in the dark had the same electrophoretic mobilities.
Analysis of the fragments in neutral agarose gel (Figure 15a)
show that the electrophoretic mobility of the DNA fragments decreased
slowly with increased photoreaction, with the only substantial shift
occurring in the sample irradiated for 24 minutes containing about 22
crosslinks per kilobase pair, as determined from radioactivity
3
measurement using H-trimethylpsoralen. This separation in neutral
gel, in which the DNA is maintained in its normal conformation,
appears to be based solely on molecular weight, with a sufficient
increase needed for a reasonable separation.
Analysis by alkaline gel electrophoresis showed that even the
samples that had been photoreacted for a short time in the presence
of trimethylpsoralen showed a substantial decrease in mobility. As
opposed to the results obtained using neutral agarose gel, under
alkaline conditions, the largest shift occurred with the most lightly
photoreacted DNA. The difference appears to be attributed to the
denaturing conditions of the alkaline gel, in which the increased
surface area affects of molecules containing only 1 or 2 crosslinks
per molecule, outweigh the molecular weight affects. In this manner -,
Cech has provided a method of analysis, unlike previous methods,
which is more sensitive to lightly crosslinked DNA, specifically to
molecules containing 0 to 1 crosslink per molecule (Cech, 1981).
B. Electron Microscopy:
In electron microscopy analysis of crosslinked DNA, the reacted
DNA is spread under totally denaturing conditions and the crosslinks
are visualized as points of contact of the single strands of DNA. In
20
this manner, it is important that the DNA concentration is kept very
low so that any contact of the single strands can, with probable
certainty, be attributed to a crosslinked pair and not a coincidental
overlap of unassociated DNA strands.
In the example shown, Hae III fragments of 0X174 RFII DNA were
photoreacted with
4,5'
,8-trimethylpsoralen for various reaction times
(Cech, 1981).
The control DNA sample (a) which contained DNA fragments irradi
ated for 1.5 minutes in the absence of drug, shows only single
stranded DNA. The sample photoreacted with drug for 0.5 minutes (b)
contained single strands of DNA as well as two strands connected by a
crosslink. The sample irradiated for 1.5 minutes in the presence of
drug (c) contained denatured regions of varying size as well as
regions having the appearance of normal double-stranded DNA. Accord
ing to Cech (Cech et al, 1977), the apparent double-stranded regions
actually contained denatured regions too small to be visualized. The
DNA sample photoreacted in the presence of drug for 24 minutes (d)
was almost entirely double-stranded in appearance with visible
denatured regions rare (Cech, 1981).
The method is useful in that it gives the location of the
crosslinks as well as the number of crosslinks. However, because one
is looking at a unit area, it is not a reliable method for quantify
ing very low extents of crosslinking (i.e. <1 crosslink per molecule)
because, in this case, the unit area observed may not be representa
tive of the sample.
C. Ethidium Bromide Fluorescence Assay:
21
Figure 16. Hae III restriction fragments of 0X174 RFII DNA
photoreacted with trimethylpsoralen and spread for electron
microscopy under totally denaturing conditions.
Ethidium bromide (3,8-diamino 6-phenyl-5-ethyl phenathridinium)
is a trypanocidal dye (Hawking, 1963; Newton, 1964).
It has been shown to interfere with nucleic acid synthesis in
10
Figure 17. Structure of ethidium bromide.
vivo (Newton, 1957; Henderson, 1963), inhibit both DNA polymerase and
the DNA dependent RNA polymerase by binding to the DNA template
(Elliot, 1963; Waring, 1964), as well as showing antiviral properties
(Dickinson et al, 1953; Vilagines and Atanasiu, 1967; Content, 1969).
Previous studies (LePecq et al, 1964; Waring, 1965) have also shown
an interaction of ethidium bromide with double-stranded nucleotides
which is characterized by a marked increase in the fluorescence of
the dye which has been attributed to the removal of the quenching by
the polar solvent as the molecule enters the hydrophobic interior of
the DNA or RNA duplex. This phenomenon will be examined in further
detail, as well as its usefulness as a basis for an analytical
technique for the detection of crosslinked DNA.
Ethidium bromide binds to two different kinds of sites on
polynucleotides, the first of which is known as the intercalative
binding site, or the fluorescent site, and is the most important. It
is this site for which the ethidium bromide has the strongest affini
ty for double-stranded polynucleotides. The binding of ethidium
bromide to the second site has a higher affinity for single-stranded
23
rather than double-stranded polynucleotides, especially at very low
ionic strengths or in the presence of a large excess of ethidium
bromide. The affinity constant for this site drops dramatically for
increased ionic strength, and in 0.1 M NaCl, the binding to this site
is considered negligible. Similarly, the quantum efficiency of the
binding to this second site is negligible compared to the quantum
efficiency of ethidium bromide bound to the first site (LePecq,
1971) . Because of this and the use of proper controls as well as
maintaining solutions at in vitro physiological ionic strengths of
0.15 M NaCl, the binding to the second site can be considered
insignificant and we will concentrate on the properties of ethidium
bromide bound to the fluorescent site.
When ethidium bromide intercalates, the quantum efficiency of
fluorescence is increased 21-fold upon binding to double-stranded DNA
and 25-fold upon binding to double-stranded RNA, and the maximum of
the absorption spectrum is shifted to longer wavelengths. Therefore,
because the fluorescence measured for a given excitation wavelength
is proportional to the quantum efficiency and to the extinction
coefficient of the compound for the same wavelength, the fluorescence
intensity emitted by a bound ethidium bromide molecule can be almost
100 times larger than the fluorescence intensity measured for a free
molecule under the same conditions (LePecq, 1971) . By exploiting
these properties, increased ethidium bromide fluorescence can be used
as a delicate probe of duplex DNA concentration.
There is also a preference for ethidium bromide for dou
ble-stranded nucleic acids at higher salt concentrations as evidenced
by the strong binding of ethidium bromide to poly (A-U) and poly
24
(I-C) but not to poly U, poly A (neutral pH) , poly I, or poly C and
only weakly to poly A-2U) and poly (A2I) (LePecq and Paoletti, 1965).
Because poly A is believed to consist of considerable local secondary
structure due to stacking interactions (Leng and Felsenfeld, 1966),
these results indicate that a double-stranded hydrogen bonded struc
ture is required for strong binding and not simply a stacked struc
ture. It is important to note that single-stranded DNA or RNA is
able to fold in on itself to form short double-stranded regions, and
ethidium bromide is able to bind these structures as well (Studier,
1969; Thomas and Spencer, 1969).
The binding to the double-stranded polynucleotides itself is
believed to be by intercalation between the base planes of the double
helix. The preferential binding of ethidium bromide to
double-
stranded nucleic acids, the occurrence of energy transfer from DNA to
ethidium bromide (LePecq and Paoletti, 1967), x-ray diffraction
studies (Fuller and Waring, 1964) , flow dichroism experiments (LePecq
and Paoletti, 1967) and the effect on the supercoiling of circular
DNA's (Crawford and Waring, 1967; Bauer and Vinograd, 1968; Bujard,
1968) all support this proposal. Further studies using Scatchard
plots and fluorometric measurements show one fluorescent binding site
per five nucleotides for DNA and one fluorescent binding site per ten
nucleotides for RNA (LePecq and Paoletti, 1967).
The intercalation of one ethidium bromide molecule is essential
ly the same as the addition of one base pair to the double helix,
which results in a slight unwinding of the DNA duplex to allow for
this addition. Therefore, for covalently closed circular DNA, which
does not allow the rotation of one strand around the other, the
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unwinding of the DNA to accommodate the ethidium bromide molecule
results in a modification of the tertiary turn number because of the
imposed topological constraint. This topological constraint there
fore limits the amount of ethidium bromide that the covalently closed
circular DNA can bind if saturated with ethidium bromide. However,
since only one nick on this type of DNA is sufficient to release all
the topological constraints, the introduction of one break in such
DNA will result in the binding of additional ethidium bromide fol
lowed by a characteristic increase in fluorescence (LePecq, 1971) .
Having discussed the binding of ethidium bromide to double-
stranded nucleotides, it is important to note the effect of various
conditions on this binding. As evidenced by the breakage without
denaturation of DNA by hydrodynamic shearing, the binding equilibria
for ethidium bromide is not affected by nucleic acid molecular weight
(LePecq, 1965) - Identical Scatchard plots for binding of ethidium
bromide were observed for DNAs of varying base composition (LePecq
and Paoletti, 1966) indicating no base preference. There are abrupt
changes in fluorescence measured at pH values resulting in either
acid or alkaline denaturation of DNA (LePecq and Paoletti, 1967), as
would be expected, at higher salt concentrations, and increased
temperature results in a lowering of the ethidium bromide binding
constant (LePecq and Paoletti, 1967).
The fluorescence properties of ethidium bromide have since been
applied towards an analytical technique for the quantitative measure
of duplex DNA, and have further been expanded to measure the extent
of DNA interstrand crosslinking by the following fluorescence assay
(Morgan and Pulleyblank, 1974; Lown et al, 1976).
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Figure 18. Ethidium bromide fluorescence assay for the
detection of crosslinked DNA.
Native, unreacted DNA is exposed to an excess of ethidium
bromide to measure the maximum increase in fluorescence. Upon heat
denaturation of the duplex DNA at high pH (>11) , the fluorescence
enhancement falls to zero due to the prevention of renaturation by
the high pH (Morgan and Paetkau, 1972). However, if a crosslink is
induced by the action of a crosslinking agent, a return of fluores
cence is observed after cooling, even under alkaline conditions,
since the crosslink serves as a nucleation site for the spontaneous
renaturation of the DNA. The observed return of fluorescence is the-i
proportional to the percent of crosslinked DNA (Lown et al, 1976).
Although the procedure is relatively easy and rapid, there are
precautions which must be considered. First, the DNA must be sat
urated with ethidium bromide to achieve maximum fluorescence enhance
ment to ensure that the total amount of duplex DNA is being measured.
Second, one must be careful to not exclude ethidium bromide binding
sites by the introduction of extensive crosslinking to again ensure
that the total amount of duplex DNA is being measured. Third, it
must be certain that the fluorescence enhancement from the interca
lation of the ethidium bromide falls on the linear region of the
spectra to accurately determine the correct amount of duplex DNA
(LePecq, 1971).
INTRODUCTION OF THE DICHLORO-N-SUBSTITUTED AZAADAMANTANES
Of the bifunctional alkylating agents previously described, only
the nitrosoureas show any activity against neoplasia of the central
nervous system (i.e. brain tumors). There are a number of factors
which make central nervous system tumors one of the most difficult to
treat. These include the surgical inaccessibility of the tumors, the
critical nature of the host tissue and the existence of the blood
brain barrier which restricts the facile penetration of polar species
into the brain tissue. The nitrosoureas themselves, although some
what effective, have inherent problems associated with them. Some of
these include cytotoxicity due to nonspecificity of alkylation and a
need for increased lipophilicity for increased membrane permeability.
Until recently, no consideration was given to the concept of
stereoselective alkylation as a means of increasing antitumor selec
tivity. Of the crosslinking agents previously studied, after the
initial alkylation, the Intermediate species was essentially free to
react with any nucleophile within a defined radius. It has now been
considered that a direct correlation of crosslinking distance with
cell cytotoxicity could be obtained if the reaction radius was
restricted to a fixed distance, and if rigid alkylating agents of
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highly defined stereochemistry and variable physiological properties
could be synthesized to not only show a potential increase for
antitumor selectivity, but which could also possibly be used as a
series of "molecular rulers" to provide an insight into the
relationship of crosslinking distance and strict stereochemistry to
DNA intermolecular crosslinking and cell cytotoxicity (Henkel, 1983).
With these ideas in mind, Dr. James G. Henkel of the University
of Connecticut has synthesized a series of compounds that meet these
stringent requirements, to be used as probes to examine the mechanism
of action leading to the formation of DNA interstrand crosslinks











Figure 19. Structures of the N-substituted azaadamantane isomers.
The N-substituted azaadamantanes have within their structures
specific properties which make them theoretically good candidates to
overcome the problems previously discussed. A nitrogen mustard
moiety is incorporated into the framework of each species giving the
?q
compounds crosslinking potential. The stereochemistry of the alkyla
ting centers for each is highly defined due to the rigid azaadaman
tane framework, and after initial alkylation at one of the centers,
the activation and subsequent alkylation of the remaining reaction
site for generating a crosslink must occur stereoselectively and at a
fixed distance. In the case of 1, its reaction sites lie on opposite
sides of the molecular framework with a reaction distance of 4.5-5.0
A, similar to the second activated species of nitrogen mustard.
Compounds 2 and 3^ have reactions sites separated by about 2.5 A,
similar to the ethylene-like crosslinks of nitrosoureas. For com
pound 2, the active sites lie on opposite sides of the structure
requiring that the stereochemistry of the formation of a crosslink
will be "anti". For compound 3, the reaction sites are on the same
side of the molecule so that alkylation must occur in a
"syn"
manner.
Finally, due to the incorporation of the large three ring system, an
increase in lipophilicity should be observed thereby leading to
possible increased membrane permeability for enhancement of central
nervous system antitumor activity (Henkel, 1983).
SPECIFIC OBJECTIVES OF RESEARCH
While the biological studies of these compounds with respect to
cytotoxcity are currently under investigation at the University of
Connecticutt, it has been the task of this laboratory to study the in
vitro interactions of these compounds with isolated DNA at the
molecular level.
The specific objectives for this work were to (1) determine the
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physiochemical properties of these compounds in aqueous solution, (2)
determine and compare the crosslinking profiles both within
and
between the two different substituted isomer series and (3) examine
the relative stability of the induced intermolecular crosslinks.
The
results obtained will be used to examine the relationship between
crosslinking of duplex DNA at the molecular level with the results
of




STABILITY OF AZAADAMANTANE ISOMERS IN AQUEOUS SOLUTION
INTRODUCTION
Time dependent crosslinking studies of the various azaadamantane
isomers with CT-DNA (Cabral, 1984; Doty, 1984) were previously
performed at constant DNA concentrations, and the percent of
cross-
linked DNA was measured as a function of reaction time at varying
drug concentrations. The results indicated that the 4,8 isomers and
the 4,9 isomers of both series of the azaadamantanes do indeed
crosslink DNA, whereas the 4,10 isomers of both series do not appear
to crosslink DNA to any appreciable extent under the same experi
mental conditions. Furthermore, the results indicated that the
maximum percent of crosslinked CT-DNA was directly related to the
initial concentration of crosslinking agent at the time of initiation
of the crosslinking reaction.
The reactions were first performed by adding the crystalline
form of the crosslinking agent directly into reaction vessels con
taining the aqueous DNA solutions. However, due to observed time
dependent solubilization of the various isomers in solution, an
alternative method was developed to initiate the crosslinking re
actions under more homogeneous conditions. Subsequently, the
crosslinking agents
were separately dissolved in aqueous solution
prior to initiation of the crosslinking reactions, thereby elimina-
ting the kinetics associated with the solubilization of the various
crosslinking compounds. However, although the kinetics of the
reactions appeared to be similar for both methods, a noticeable re
duction in the overall extent of crosslinking was observed when the
drugs were introduced in aqueous form. It was also observed that the
reaction profiles further varied for the same crosslinking agent
depending upon the amount of time that the agent was allowed to spend
in the aqueous solution prior to initiating the crosslinking re
actions. Both of these observations would suggest a reduction in the
initial concentration of active crosslinking species due to exposure
of the drugs to aqueous solution prior to initiation of the cross-
linking reactions .
Further experiments performed at the University of Connecticut
(Henkel, 1984) have shown a time dependent increase in the electro
chemical measurement of chloride ion concentration upon addition of
the azaadamantane isomers to aqueous solution. This would suggest a
time dependent loss of the azaadamantane chloride substituents to
form the expected adamantyl aziridinium ion intermediates which could
possibly lead to the formation of inactive crosslinking products due
to hydrolysis.
Based on these results, it was deemed necessary to determine the
extent to which possible hydrolysis of the intermediates may decrease
crosslinking efficiency of
the azaadamantane isomers by lowering the
effective concentration of active crosslinking agent. Therefore, a
novel modification of the ethidium bromide assay procedure was used
to quantitatively
measure the rate of loss of active crosslinking
species as a function of the amount of time that the drugs were
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dissolved in aqueous solution prior to exposure to the CT-DNA and
initiation of the crosslinking reactions. This measured rate of loss
of active crosslinking agent will then be taken into account to more
accurately compare the crosslinking efficiencies of the 4,8 and 4,9




The azaadamantane crosslinking agents were kindly provided by
Dr. James Henkel, Department of Medicinal Chemistry, University of
Connecticut. The molecular weights of the dichloro-N-methyl
azaadamantanes (C H NCI :HC1) are 256.6 grams per mole. The
molecular weight of the ^,9-dichloro-N-piperdinoethyl azaadamantane
(C1,H_,N_Cl-:2HCl:iHo0) is 399 grams per mole and the molecular
16 26 L L L
weight of the 4,8-dichloro-N-piperdinoethyl azaadamantane
(C,,H/,N0C1 :HCL) is 390 grams per mole. The molecular weight of
16 26 2 Z
mechlorethamine hydrochloride (N-methyl-bis (2-chloroethyl) amine) , or
HN2, a well established interstrand crosslinking agent, is 192.5
grams per mole. The crosslinking agents were weighed on a Mettler
Analytical Microbalance using a microcapsule, and 0.25 to 1 mg.
samples of each were used for all reactions.
B. Material Safety Data and Precautions:
The following data on mechlorethamine vas taken from the Materi
al Safety Data Sheet obtained from Sigma Chemical Company:
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Product Name: Mechlorethamine Hydrochloride
Hazard Data:
Poison
1980 RTECS AIA2 100000
Suspected carcinogen
TLV and Source: LD50 = 10 mg/kg oral-rat
Acute Effects of Exposure:
Swallowing - Poison. May be fatal if swallowed.
Skin Absorption - Poison. May be fatal if absorbed through
skin. Vesicant.
SCU-Rat LD50 - 1900 ug/kg
Inhalation - Poison. May be fatal if inhaled. Do not breathe
dust, vapor, mist or gas.
Eye Contact - Do not get in eyes .
Emergency and First Aid Procedures:
Swallowing
- Call a physician immediately.
Exposure to Skin - Wash skin with copious amount of water for at
least 15 minutes, followed by 2% sodium
thiosulfate. Remove contaminated clothing
and shoes. Call a physician.
Inhalation - Move to fresh air. If breathing becomes difficult,
call a physician.
Exposure to Eyes - Flush eyes with copious amount of water for
at least 15 minutes. Call a physician.
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Safety Precautions Taken in Laboratory:
Protective gloves worn.
Eye protection worn.
Long-sleeve laboratory coats worn.
Chemical used in microgram quantities.
Chemical used in mechanically exhausted area.




The DNA used for all experiments was Calf-Thymus DNA (Type 1 ,
polymeric) which was purchased from Sigma (Lot? 525-9585) and has a
nucleotide-phosphate extinction coefficient of 6600 1 mole "* cm at
260 nm. (Sigma). A stock solution was prepared by adding 69.8 mg. of
CT-DNA to 66 ml. of 20 mM sodium phosphate at pH=7 containing 0.15 M
NaCl and allowing the mixture to stir overnight to dissolve. The
absorbance at 260 nm. of the resulting solution was measured on a
Perkin-Elmer 552A UV/Vis Spectrophotometer in a 0.2 cm. cell. The
stock DNA solution was found to be 2.49 mM in nucleotide-phosphate
(A,,- =16.4) . Aliquots of the solution were then placed in 1.9 ml.
Z60
polypropylene microcentrifuge tubes and frozen. As needed, samples
were allowed to reach ambient temperature, and subsequent dilutions
were made with 20 mM sodium phosphate at pH=7 containing 0.15 M NaCl
to result in 10 ml. of 0.30 mM nucleotide-phosphate (A0/=2) CT-DNA
260
solutions. Aliquots of the 0.30 mM nucleotide-phosphate CT-DNA were
then placed in 500 ul. polypropylene microcentrifuge tubes and
frozen. All experiments were performed using the 0.30 mM nucleotide-
phosphate (A , =2) CT-DNA solutions which were thawed as needed.
36
D. Standard Ethidium Bromide Assay Solution Preparation:
The ethidium bromide (3,8-diamino-6-phenyl-5-ethyl phenanthri-
dinium) was purchased from Sigma (Lot# E-8751) and has a molecular
weight of 394.3 grams per mole and an extinction coefficient of 5450
1 cm at 480 nm. (Sigma). The standard ethidium bromide assay
solution was prepared according to previous literature (Lown et al,
1976) with the modification of 0.2 mM EDTA instead of 0.4 mM EDTA.
This solution contained 0.2 mM EDTA and 0.5 ug/ml ethidium bromide in
20 mM sodium phosphate at pH=11.4, resulting in a solution that was
1.27 uM in ethidium bromide. A stock solution was prepared by
dissolving 10.5 mg ethidium bromide to a total volume of 100 ml with
20 mM sodium phosphate at pH=ll. containing 0.2 mM EDTA. The
absorbance of this stock solution was measured on a Perkin-Elmer 552A
UV/VIS Spectrophotometer in a 0.2 cm cell. The resulting solution
was found to have an A. =1.48, corresponding to 0.272 mM ethidium
4oU
bromide. Appropriate dilutions were made with 20 mM sodium phosphate
at pH=11.4 containing 0.2 mM EDTA to result in 1 liter of standard
ethidium bromide assay solution at 0.5 ug/ml ethidium bromide. Due
to the photosensitivity of ethidium bromide, both solutions were
placed In opaque containers and stored at 5C.
E. Buffer Solutions:
The sodium phosphates used for the buffer solutions vere
NaH PO, :H0, molecular weight equals 137.99 grams per mole, purchased
2 4 2
from J.T. Baker (Lot# B-5818); Na2HP0^,, molecular weight equals
141.965 grams per mole, purchased from Andor Labs (Lot# 2582) and
Na PO :12H 0, molecular weight equals 380.12 grams per mole, pur-
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chased from J.T. Baker (Lot# 41-3836). The NaCl used was purchased
from J.T. Baker (Lot# 3624-1) and has a molecular weight of 58.4
grams per mole .
F. Measure of DNA Interstrand Crosslinking:
For all experiments, the measure of the extent of DNA inter
strand crosslink formation was based on variations of an ethidium
bromide fluorescence assay (LePecq, 1971; Morgan and Pulleyblank,
1974; Lown et al, 1976; Lown, 1979). Ethidium bromide binds by
intercalation into duplex DNA resulting in an enhancement of fluores
cence once it enters the hydrophobic interior of the DNA (Morgan and
Pulleyblank, 1967) . Upon heat denaturation of the duplex DNA in the
presence of ethidium bromide at high alkaline pH (>11), the fluores
cence enhancement falls to zero due to the high pH preventing the
renaturation of regions of self-complimenarity (Morgan and
Pulleyblank, 1972) . However, if an interstrand crosslink is induced
by the action of a crosslinking agent, a return of fluorescence after
heat denaturation and cooling is observed, even under high alkaline
conditions, since the crosslink serves as a nucleation site for the
spontaneous renaturation of the DNA (Lown et al, 1976). This return
of fluorescence is then proportional to the amount of duplex DNA
containing at least one
interstrand crosslink. Therefore, the return
of fluorescence is proportional to the amount of crosslinked DNA. An
outline of the procedure is shown in Figure 1.1.
G. General Crosslink Assay Procedure:






















(Lown et al, 1976)
Figure 1.1. Protocol for the ethidium bromide fluorescence assay.
conditions of pH=7, 37C and 0.15 M NaCl. A 0.25 to 1 mg sample of
the crosslinking agent contained in a microcapsule was pre-dissolved
in 20 mM sodium phosphate at pH=7, containing 0.15 M NaCl prior to
the initiation of the crosslink reaction. Reactions were then
initiated at t=t by mixing equal volumes of the crosslinking agent
and CT-DNA at twice the reactions concentrations to a total volume nf
300 to 500 ul. At specific reactions times, 30 ul aliquots of the
reactions mixture were quenched in 1 ml of standard ethidium bromide
assay solution contained in a 1.9 ml polypropylene microcentrifuge
tube.
A control sample of the same CT-DNA used in the crosslinking
reaction was prepared by diluting 30 ul of the uncrosslinked CT-DNA
solution at twice the reaction concentration with 30 ul of 20 mM
sodium phosphate at pH=7 containing 0.15 M NaCl. A 30 ul aliquot of
this mixture was similarly added to 1 ml of standard ethidium bromide
assay solution
contained in a 1.9 ml polypropylene microcentrifuge
tube.
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The fluorescence of the reactions samples and a control sample
was measured on a Perkin-Elmer Fluorescence Spectrophotometer MPF 3L.
To ensure that ethidium bromide binding sites were not being excluded
by extensive crosslinking and that the crosslinking reactions did not
lead to any DNA degradation, the measured fluorescence enhancement of
the reactions samples (F (X)) was carefully checked to guarantee
that it was equal to the measured fluorescence enhancement of the
control sample (F (C)), as shown in Figure 1.1. The reactions and
control sample vials were then placed in drilled holes in plexiglass
plates and simultaneously heat denatured for 2 minutes at 98C in a
Fisher High Temp Bath Model 160 filled with sand. The samples were
then quenched on ice for 5 minutes and allowed to reach ambient
temperature by placing in a water bath at room temperature for 15
minutes. The fluorescence of the samples was remeasured to measure
the extent of fluorescence return of the reaction samples (F (X)),
and to measure the background fluorescence of ethidium bromide in the
presence of denatured single-stranded DNA (F (X)), as indicated by
the control sample. The percent of crosslinked DNA was then cal
culated from the fluorescence data.
H. Fluorescence Measurements:
The fluorescence of all samples was measured on a Perkin-Elmer
Fluorescence Spectrophotometer MPF 3L set in ratio mode at ratio
setting 2. The sensitivity
of the instrument was usually set at 10,
with the excitation and emission slits both generally set at 16. All
measurements were made using a 0.2 cm cell, with the samples at
ambient temperature. Fluorescence measurements were made by setting
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the excitation wavelength at 520 nm and scanning the emission spectra
from 540 to 640 nm with a 3 nm per second scan rate. The fluores
cence measurements were also obtained by measuring the fluorescence
of the samples at the maximum emission wavelength of 590 nm.
An external ethidium bromide reference containing 6.8 uM
ethidium bromide in 20 mM sodium phosphate at pH=7 was used as a
control to note any instrumental and/or experimental fluctuations.
I. Analysis of Fluorescence Data:
The measured fluorescence due to intercalated ethidium bromide
is directly proportional to the amount of duplex DNA, and at the high
pH of the standard ethidium bromide assay solution (11.4) only
crosslinked DNA can return to duplex form after heat denaturation.
Therefore, the ratio of ethidium bromide fluorescence after heat
denaturation for each of the reactions samples (F (7)), to the
ethidium bromide fluorescence before heat denaturation for each
sample (Finn(X)) is proportional to the amount of crosslinked DNA.
The fluorescence of the denatured, uncrosslinked control sample
(F (C) ) is subtracted from the previous values to correct for the
background fluorescence due to ethidium bromide in the presence of
denatured, single-stranded DNA. For Calf-Thymus (Type 1, polymeric)
DNA of unknown molecular weight, the ratio is reported as the percent
of crosslinked DNA, and can be calculated using Equation 1.1.
However^ since only one crosslink per DNA duplex is sufficient to
induce rapid renaturation upon cooling after heat denaturation (Lown
et al, 1976), the actual number
of crosslinks per DNA molecule is
undetermined. Furthermore, since the DNA segments have an unequal
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Equation 1.1
% Crosslinked DNA =
F&(X)-FA(C)
Fioo(x)-Vc)
distribution of molecular weights, determination of the actual number
of DNA molecules is impossible.
J. Fluorescence of Bound Ethidium Bromide as a function of Duple-:
DNA Concentration:
In order to accurately measure the amount of duplex DNA by bound
ethidium bromide fluorescence, the ethidium bromide concentration
must be sufficient to saturate all the possible DNA intercalation
sites (1 site/2 base pairs) . To ensure that this condition was met
for the reaction samples, various sized aliquots of CT-DNA, at the
reaction concentration of 0.15 mM nucleotide-phosphate (A, =1) , were
added to 1 ml of standard ethidium bromide assay solution, and the
observed fluorescence was measured as a function of DNA duplex
concentration. The tested aliquot sizes ranged from 5 to 40 pi,
resulting in solutions that were 3.73 to 28.85 pi in nucleotide-phos
phate, respectively. The 5 to 40 yl aliquots were obtained using a
Gilson Pipetman P100 micropipette. A plot of the measured fluore
scence of bound ethidium bromide as a function of duplex DNA
concentration indicated that 1 ml of standard ethidium bromide assay
solution is sufficient to saturated all the duplex DNA in aliquots up
to 35 pi of the 0.15 mM nucleotide-phosphate (A =1) CT-DNA, corre
sponding to 25.36 pM in nucleotide-phosphate. It was therefore
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decided to quench 30 pi aliquots of the reaction mixtures into 1 ml
of standard ethidium bromide assay solution, resulting in a solution
that is 21.84 pM in nucleotide-phosphate.
K. Determination of Heat Denaturation Time:
Heat denaturation of all samples was accomplished at 98C in a
Fisher Temp Bath Model 160 filled with sand. In order to maximize
denaturation, but minimize DNA degradation due to excessive heating,
the amount of time for heat denaturation was determined by adding 30
pi aliquots of CT-DNA, at the reaction concentration of 0.15 mM
nucleotide-phosphate (A_
,=!) ,
to 1 ml aliquots of standard ethidium
zoU
bromide assay solution and heat denaturing the samples for various
amounts of time. The fluorescence of the samples was then measured
by setting the excitation wavelength at 520 nm and scanning the
emission spectra from 540 to 640 nm with a 3 nm per second scan rate.
Results indicated that denaturation times below 2 minutes led to
incomplete denaturation, and that denaturation times above 2 minutes
led to DNA degradation. Based on these results, a 2 minute denatur
ation time optimized the required conditions and was used for all of
the experiments.
L. Modification of the General Assay Procedure to Determine
Stability of Crosslinking Isomers in Aqueous Solution:
A 0.25 to 1 mg sample of crosslinking agent, weighted on a
Mettler Analytical Microbalance and contained in a microcapsule, was
added to a calculated volume of 20 mM sodium phosphate at
pH=~
containing 0.15 M NaCl which would result in an equal volume dilution
43
with the CT-DNA solution to give the desired drug to
nucleotide-phosphate concentration ratio. For all reactions, the
CT-DNA concentration was held constant by initiating reactions at
0.30 mM nucleotide-phosphate (A0/=2) . The desired drug to nucleo-
zoO
tide-phosphate concentration ratios were accomplished by adding a
pre-weighed sample of the crosslinking agent to a sufficient amount
of buffer solution which would result in the desired drug concen
tration. The crosslinking agent was then allowed to remain in the
buffer for a series of time intervals ranging from 30 seconds to 30
minutes. At specific time intervals, 30 pi of the drug solution was
added to 30 pi of the 0.30 mM nucleotide-phosphate (A_, =2) CT-DNA
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and the reactions initiated to t=t . Based on previous reaction
profiles (Cabral, 1984; Doty, 1984), the 4,9 N-methyl isomer re
actions were allowed to react for 2 minutes, the 4,8 N-methyl isomer
for 6 minutes, the 4,8 N-pipercinoethyl isomer for 10 minutes and the
4,9 N-piperdinoethyl isomer for 4 minutes. At these reactions times,
30 pi of the reaction mixtures were quenched in 1 ml of standard
ethidium bromide assay solution. All samples were then mixed on a
Vortex mixer and centrifuged for 1 minute on a Fisher microcentri
fuge. The fluorescence of the samples was measured as previously
described, the samples were heat denatured and the fluorescence
remeasured. The percent of crosslinked CT-DNA was then plotted as a
function of time that the drug spent in aqueous solution prior to
initiation of reaction to determine the stability of active
cross-
linking species in aqueous solution.
RESULTS AND DISCUSSION
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Any loss of active crosslinking species for each of the drugs
was observed by plotting the measured percent of crosslinked CT-DNA
at identical reaction times as a function of the amount of time the
crosslinking agents were pre-dissolved in aqueous solution prior to
initiation of the crosslinking reaction. Since the reaction times
were held constant for each of the crosslinking agents, any decrease
in the measured extent of crosslink formation could be attributed to
the loss of active crosslinking species due to aqueous solution
instability.
As shown in Figure 1.2, within experimental error, the measured
extent of crosslinking by mechlorethamine after a 10 minute reaction
appears unaffected by pre-dissolving times of up to 20 minutes.
Because mechlorethamine yields an aziridinium ion intermediate upon
exposure to aqueous solution, these results indicate that there is no
appreciable reduction in the aziridinium ion concentration due to
extended exposure to aqueous solution for up to at least the tested
20 minutes. Therefore, the effective concentration of the active
crosslinking aziridinium ion intermediate at the tire of initiation
of the crosslinking reactions, was independent of the pre-dissolving
time and was essentially the same as the calculated initial concen
tration of mechlorethamine. These results are in agreement with
previously published work (Kohn, 1966) indicating the aqueous so
lution stabilitv of the aziridinium ion intermediate of mechloreth
amine ,
As shown in Figures 1.3 and 1.4, in contrast to mechlorethamine,
the 4,8 and 4,9 N-methyl series of azaadamantanes do exhibit
decreasing extents of crosslink formation at identical reaction times
A5
Figures I. 2-1. 6. Aqueous solution stability of the N-substituted
azaadamantane isomers and mechlorethamine.
The figures represent the dependence of the efficiency of
crosslinking of Calf-Thymus DNA (Type 1, polymeric) on the amount of
time that the drugs were pre-dissolved in aqueous solution prior to
initiation of the crosslinking reactions. Reactions were performed
at 37C in 20 mM sodium phosphate buffer at pH=7, 0.15 M NaCl
containing 0.15 mM nucleotide-phosphate. Pre-weighed samples of the
crosslinking agents were pre-dissolved in a sufficient amount of
buffer to give the desired initial drug to nucleotide-phosphate (D/P)
concentration ratio. The D/P ratios used for all of the crosslinking
agents except the 4,8 N-methyl azaadamantane were set at D/P=6. The
D/P ratio for the 4,8 N-methyl azaadamantane was raised to D/P=8 due
to the previously observed lower extents of crosslink formation
(Cabral, 1984; Doty, 1984) . The drugs were pre-dissolved in aqueous
buffer for varying amounts of time prior to initiating the
crosslinking reactions. The reactions vere then initiated by mixing
equal volumes of the drug and CT-DNA solutions at twice the reaction
concentrations. For each of the crosslinking agents, the tire of
reaction was held constant to observe any measured decrease in
crosslink formation due to a time dependent loss of active


































6 1 1 A
ISOMER SOLUTlCS LIFETIME (MIS )
(PR'OP TO IN:TiA'lNG X-LINK REACTC-0
1 E


























ISOMER SOLUTION LIFETIME (min )
































ISOMER SOLUTION LIFETIME (MIN )




Figure 1.4. Solution stability of the 4,9-dichloro-N-methyl
azaadamantane .
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as a function of increasing amounts of pre-dissolving time. These
results indicate a time dependent decrease in the concentration of
active crosslinking species at the time of initiating the
crosslinking reactions due to aqueous solution instability of the
N-methyl isomers.
In order to compare the rate of loss of active species between
the two isomers, a quantitative measure was made from the resulting
plots of the measured percent of crosslinked CT-DNA as a function of
the aqueous solution lifetime (pre-dissolving time) . For each
isomer, the resulting plots were extrapolated to the maximum percent
of crosslinked CT-DNA occurring at t=t , and the pre-dissolving time
for which half of this maximum value occurred was determined from the
plot. This pre-dissolving time indicates the time at which half of
the initial concentration of active crosslinking species was present
at the time of initiating the crosslinking reaction, and was there
fore designated as the half-life in aqueous solution for the corre
sponding isomer.
Similarly, since the pre-dissolving times used for previous
experiments (Cabral, 1984; Doty, 193-i) were arbitrarily set at 3
minutes, it was necessary to determine the percent of the initial
concentration of active crosslinking species remaining after 3
minutes in aqueous solution. From the plots, the extent of crosslink
formation occurring after 3 minute pre-dissolving times t.-as expressed
as a percent of the extrapolated maximum extent of crosslinking at
t=t . This percent of the maximum extent of crosslinking is then
o




The results of the above calculations for the 4,8 and 4,9
N-methyl azaadamantanes are summarized in Tables 1.1 and 1.2. As
shown, the average half-life in aqueous solution for the 4,8 N-methyl
isomer was determined to be 5.^0 minutes, with a relative error of
1.85 percent. The average half-life of the 4,9 N-methyl isomer was
determined to be 1.76 minutes, with a relative error of 2.27 percent.
A comparison of the half-lives indicate that the rate of loss of
active species in aqueous solution is slower for the 4,8 isomer than
for the 4,9 isomer. As would be expected from these results, the
percent of the initial concentration of active crosslinking species
remaining after the previously employed 3 minute pre-dissolving times
was greater for the 4,8 isomer than for the 4,9 isomer, 70.75 and
30.3 percent respectively.
As shown in Figures 1.5 and 1.6, the 4,8 and 4,9 N-piperdino-
ethyl series of azaadamantanes also exhibit decreasing extents of
crosslink formation as a function of increasing amounts of
pre-dissolving times. Therefore, the half-lives in aqueous solution
and the percent of the initial concentration of active crosslinking
species remaining after 3 minute pre-dissolving times were calculated
as previously described.
The results of the calculations for the ^,8 and 4,9
N-piperdinoethyl azaadamantanes are summarized in Tables 1.3 and I. A.
As shown, the average half-life in aqueous solution for the 4,8
N-piperdincethyl isomer was determined to be 13.35 minutes, with a
relative error of 0.37 percent. The average half-life for the ,9
N-piperdinoethyl isomer vas determined to be 5.55 minutes, with a
relative error of 6.31 percent. A comparison of the half-lives
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Tables I. 1-1.4. Summarized results of the aqueous solution
stabilities of the N-substituted azaadamantanes.
Data from Figures 1. 3-1.6 representing solution stability dependence
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indicate that, like the N-methyl series, the rate of loss of active
crosslinking species in aqueous solution is slower for the 4,8 isomer
than for the 4,9 isomer. And similarly, the percent of the initial
concentration of active crosslinking species remaining after 3 minute
pre-dissolving times is greater for the 4,8 isomer than for the 4,9
isomer, 84.75 and 72.8 percent, respectively.
From the preceding results, it can be seen that for both the
N-methyl series and the N-piperdinoethyl series of azaadamantanes,
the 4,8 isomers exhibit longer half-lives than do the 4,9 isomers.
Since the only difference between the 4,8 and 4,9 isomers within the
same series is the stereochemistry of the chloride substituents,
these factors must somehow influence the stability of the adamantyl
aziridinium ion intermediate in aqueous solution. At present, the
exact nature of these stereochemical influences is unknown.
In comparisons of the same isomers between the two series, as
shown in Table 1.5, it can be seen that the N-piperdinoethyl isomers
exhibit longer half-lives than do the corresponding N-methyl isomers.
These observed differences in the aqueous solution stability for the
same isomers can only be attributed to the differences in the nitro
gen substituents. Replacement of the methyl group by the
piperdinoethyl moiety appears to help stabilize the adamantyl
aziridinium ion intermediate. Possible factors for this increased
stabilization include electrostatic and/or steric interactions due to
he increased size and nature of the piperdinoethyl substituent. To




4,8-+EJJ_L 4,9-*E__L 4,8-^_^___\Lt_-_L 4,9-FLt_W_l____i,
HALF-LIFE (MIN.) 5.40 1.76 B.35 5.55
ROTD 4,8/4,9 3.07 2.41
K_1D 4 ,8-^ED__/4 ,8-Wi_H_J_____, 0.404
HYLRr_'JD 4,9-M.'IH_/4,9riJlt_r_!___J 0.317
Table 1.5. Solution stability summary for the
N-substituted azaadamantanes.
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It can now be concluded that for the previous experiments
(Cabral, 1984; Doty, 1984) the reduction In the measured extent of
crosslinking observed for when the crosslinking agents were added to
the DNA in aqueous form was due to succeptibility of the adamantyl
aziridinium ion intermediates to hydrolysis in aqueous solution as a
function of time, as shown in Scheme 1. The reduction in the
measured extent of crosslink formation would therefore depend on the
effective concentration of active crosslinking species at the time of
initiation of the crosslinking reaction, which is a function of the
rate of loss of active species and the amount of time that the drug
was allowed to spend in aqueous solution prior to addition to the
DNA.
-Ci
i; = n t Jffoji
Scheme 1.1. Hydrolysis of the 4,8-dichlcro-N-methyl azaadamantane.
Similar to mechlorethamine, the azaadamantanes spontaneously
form an aziridinium ion intermediate through an anchimeric effect cf
the nitrogen. This aziridinium ion is then subject to hydrolysis
allowing for the formation of the second aziridinium ion which is
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also subject to hydrolysis. A single resulting hydroxyl group would
render the compound ineffective as a crosslinking agent since it has
been previously shown, for nitrosoureas, that hydroxyl moieties are
inadequate leaving groups for allowing alkylation of the DNA nucleic
strands (Lown et al, 1980).
Brookes and Lawley (1961) have previously reported the aqueous
solution half-life of mechlorethamine to be approximately 2.2 hours.
This increase in aqueous solution stability is probably due to the
increased stability of the mechlorethamine aziridinium ion intermedi
ate. The freedom of rotation associated with mechlorethamine allows
for the formation of a stable aziridinium ion, whereas the conforma
tional rigidity of the azaadamantane framework increases the distance
between the electron donating nitrogen and the electron deficient
carbon atom. This increased distance would be expected to decrease
the stability of the adamantyl aziridinium ion intermediate allowing
for hydrolysis under milder conditions than necessary for the
aziridinium ion intermediate of mechlorethamine. Therefore, it can
be rationalized that the reaction conditions of 37C, pH=7 and and a
maximum of 20 minutes in aqueous solution prior to initiation of the
crosslinking reactions were insufficient to significantly hydrolyze
the aziridinium ion of mechlorethamine, but were adequate to allow
hydrolysis of the less stable adamantyl aziridinium ion intermediate.
It can further be rationalized that, because of this succeptibility
to rapid hydrolysis, the azaadamantane isomers would be of little or
no pharmacological significance.
These results also raise some interesting problems. If the
aqueous solution stability of the adamantyl aziridinium ion
interme-
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diate is increased, one may expect that the crosslinking efficiency
would decrease due to possible low reactivity with the nucleic acid
bases. Conversely, if the aqueous solution stability of the
adamantyl aziridinium ion is decreased, one may expect a faster rate
of hydrolysis yielding inactive crosslinking species resulting,
again, in a decreased crosslinking efficiency. However, with the
azaadamantane isomers, the strict stereochemistries and the fixed
distances between alkylating centers must also be taken into consid
eration. These problems will be the focus of Chapter II.
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CHAPTER II
AZAADAMANTANE CROSSLINKING REACTION ISOTHERMS
INTRODUCTION
In order to more accurately compare the crosslinking efficien
cies and the initial rates of crosslink formation of the 4,8 and 4,9
azaadamantane isomers both within and between the two N-substituted
series, it was necessary to initiate the crosslinking reactions at
equivalent concentrations of active crosslinking species. Therefore,
the pre-dissolving times for the 4,8 isomers of both series were
arbitrarily set at 3 minutes, and the pre-dissolving times for the
4,9 isomers which resulted in the same percentage of remaining active
crosslinking species as the 4,8 isomer of the same series was deter
mined from the plots of the measured percent of crosslinked CT-DNA as
a function of pre-dissolving time. As shown in Tables 1.2 and I.& in
Chapter I for the 4,9 N-methvl and 4,9 N-piperdinoethyl isomers,
these pre-dissolving times were determined to be 0.75 and 1.65
minutes, respectively.
In this manner, the drug to nucleotide-phosphate concentration
(D/P) ratios are no longer based on the initial weight of the
cross-
linking agents, but are more accurately based on the concentrations
of the active crosslinking species at the
time of initiation of the
crosslinking reactions. Therefore, any observed differences in the
initial rates of crosslink formation by each of the isomers in the
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same N-substituted series at identical D/P ratios may be attributed
to the different stereochemistries of the two isomers. Similarly,
any observed differences in the crosslinking behavior exhibited by
the same isomer between the two N-substituted series at the same D/P
ratios may be attributed to the effects of the different nitrogen
substituents. If, however, the efficiency of crosslinking formation
is unaffected by the differing stereochemistries or the varying
nitrogen substituents, but only effected by the different rates of
hydrolysis both before and during the crosslinking reactions, the
greater crosslinking efficiency may be expected for the more hydro
lysis resistant isomers. That is, the efficiency of crosslink
formation may be expected to be in the order of 4,8 N-piperdinoethyl
> 4,9 N-piperdinoethyl > 4,8 N-methyl > 4,9 N-methyl.
EXPERIMENTAL
A. Materials and Methods:
The crosslinking agents, CT-DNA solution, standard ethidium
bromide assay solution and the general crosslinking assay procedure
were all as outlined in Chapter I.
All reactions were performed in vitro at the physiological
conditions of pH=7, 37C and 0.15 M NaCl. The reaction concentration
of the CT-DNA was held constant at 0.15 mM in nucleotide-phosphate,
and the extent of crosslinking was measured as
a function of time for
each isomer at various drug to nucleotide-phosphate concentration
ratios. Reactions with mechlorethamine, a well established cross-
linking agent, were performed with each azaadamantane crosslinking
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reaction to serve as a positive control.
B. Modification of the General Assay Procedure to Determine the Time
Dependent Crosslinking Reaction Profiles of the Azaadamantane
Isomers:
A 0.25 to 1 mg. sample of the crosslinking agents contained in a
microcapsule was added to 0.25 to 20 ml. of 20 mM sodium phosphate at
pH=7 containing 0.15 M NaCl which would result in an equal volume
dilution with the CT-DNA at 0.30 mM in nucleotide-phosphate to give
the desired drug to nucleotide-phosphate concentration ratio at the
time of initiating the crosslinking reactions.
In order to account for the different aqueous solution stabili
ties of the various isomers, it was necessary to establish the actual
drug to nucleotide-phosphate (D/P) concentration ratios based on the
concentrations of active crosslinking species at the time of initia
ting the crosslinking reactions, [D(r)]. Therefore, the pre-dissol
ving times for the 4,8 isomers of both the N-methyl and N-piperdino
ethyl series were arbitrarily set at 3 minutes, and the percent of
remaining active crosslinking species was determined from the aqueous
solution stability plots. The pre-dissolving times for the 4,9
isomers of each series which resulted in the same percent of remain
ing active crosslinking species as the 4,8 isomer of the same series
were also determined from the aqueous solution stability plots. The
pre-dissolving times used and the corresponding percent of remaining
active crosslinking species for each isomer are summarized in Table
II. 1. Therefore, by holding the DNA concentration constant at 0.30
mM in nucleotide-phosphate and knowing the percent of remaining
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4,8-me__l 4,9-MEIHYL 4,SH_HJ4JiNJ___L 4,9-Pli^_)JN__l_L




3.00 0.75 3.00 1.65
% FETC_NIN3 AFTER
TI>E LEED 70.75 70.75 84.75 84.75
Table II. 1. Pre-dissolving times used and the corresponding percent
of remaining active species for each of the
azaadamantane isomers.
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active species at the time of initiating the crosslinking reactions
and the initial weight of the crosslinking agent, the initial concen
tration of crosslinking agent, [D(i)], can be calculated using the
following equations:
[D(r)] = D/P X [CT-DNA]
[D(r)] = [D(i)] X (fraction remaining)
[D(i)] = [D(r) ] /(fraction remaining)
An example can be shown for the 4,8 N-methyl isomer at a drug to
nucleotide-phosphate concentration ratio of 7.08 using the set
pre-dissolving time of 3 minutes which results in 70.75 percent of
remaining active crosslinking species as follows:
7.08 mM active drug
[D(r)] = X 0.30 mM nucleotide-phosphate
1 mM nucleotide-phosphate
[D(r)] = 2.124 mM active drug
[D(i)] = 2.124 mM active drug/0.7075
[D(i)] = 3.002 mM crosslinking agent
The volume of buffer in which the crosslinking agent is then
pre-dissolved can then be adjusted to give the desired concentration.
Since mechlorethamine is stable in aqueous solution, the
pre-dissolving time was arbitrarily set at 3 minutes and the




crosslinking agents were pre-dissolved for the
specific amounts of time, an equal volume dilution was made with the
CT-DNA and the reactions were initiated at t=t At various reaction
o.
times, 30 ul aliquots of the reaction mixtures were quenched in 1 ml
of standard ethidium bromide assay solution contained in a 1.9 ml
polypropylene microcentrifuge tube. The samples were then treated as
previously described, and the percent of crosslinked DNA was plotted
as a function of time.
RESULTS AND DISCUSSION
The measured percent of crosslinked CT-DNA was plotted as a
function of the reaction time for each of the azaadamantane isomers
at various drug to nucleotide-phosphate concentration ratios. The
resulting time dependent crosslinking profiles for each of the drugs
were then compared to note the effect of varying the initial
concentration of active crosslinking species and the effects of the
various stereochemistries and the nitrogen substituents on the
efficiency of crosslink formation.
The crosslinking reaction profiles for each of the separate
isomers at three different drug to nucleotide-phosphate concentration
ratios are shown in Figures II.1-II.4. For each isomer, an increase
in the initial concentration of active crosslinking species at the
time of initiating the crosslinking reactions results in an increase
in the maximum extent and initial rate of crosslink formation.
However; the reaction time at which the maximum extent of crosslink
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Figures II.1-II.4. Time dependent crosslinking reaction profiles for
each of the individual N-substituted azaadamantanes.
The figures represent the time dependent crosslinking of Calf-Thymus
DNA (Type 1, polymeric) by each of the individual N-substituted
azaadamantanes at three different drug to nucleotide-phosphate
concentration ratios. Reactions were performed at 37C in 20 mM
sodium phosphate buffer at pH=7, 0.15 M NaCl containing 0.15 mM in
nucleotide-phosphate CT-DNA. Pre-weighed samples of the crosslinking
agents were pre-dissolved in a sufficient amount of buffer to give
the desired drug to nucleotide-phosphate concentration ratio after
the determined pre-dissolving times and taking into account the
aqueous solution stability of the azaadamantane isomers. The
reactions were then initiated by mixing equal volumes of the drug and
CT-DNA solutions at twice the reaction concentrations. The percent
of crosslinked DNA was then measured as a function of reaction time.
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Figure II. 1. Time dependent crosslinking of CT-DNA by the 4,8-
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Figure II. 2. Time dependent crosslinking of CT-DNA by the
4,9-
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Figure II. 3. Time dependent crosslinking of CT-DNA by the 4, 5.



























Figure II. 4. Time dependent crosslinking of CT-DNA by the
,9-
dichloro-N-piperdinoethyl azaadamantane at three drug to
nucleotide-phosphate concentration ratios.
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formation is achieved for each isomer is essentially unaffected by
the change in the drug to nucleotide-phosphate concentration ratio,
with the 4,8 N-methyl isomer reaching a maximum extent of crosslink
formation after approximately 8 minutes, the 4,9 N-methyl isomer
after approximately 4 minutes, the 4,8 N-piperdinoethyl isomer after
approximately 27 minutes and the 4,9 N-piperdinoethyl isomer after
approximately 8 minutes.
The reaction profiles for each isomer also show an apparent loss
of DNA crosslinks after reaching the maximum extent of crosslink
formation. This phenomena will be the topic of Chapter III, in which
it will be discussed in greater detail.
From the reaction profiles for each isomer, cross-sectional
plots were made of the percent of crosslinked CT-DNA at specific
reaction times as a function of the drug to nucleotide-phosphate
concentration ratio. As shown in Figures II. 5 and II. 6 for the 4,9
N-methyl and the 4,9 N-piperdinoethyl isomers, respectively, the
percent of crosslinking appears to be stoichiometric with the drug to
nucleotide-phosphate concentration ratio up to a point after which
the percent of crosslink formation begins to level off due to
saturation of the available DNA binding sites. The drug to
nucleotide-phosphate concentration ratios at which saturation begins
is approximately 2.5 for the 4,9 N-methyl isomer and approximately 3
for the 4,9 N-piperdinoethyl isomer.
Figures II. 7 and II. 8 indicate the cross-sectional plots of the
percent of crosslinked CT-DNA at specific reaction times as a
function of the drug to nucleotide-phosphate concentration ratio for
the 4,8 N-methyl and the 4,8 N-piperdinoethyl isomers, respectively.
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Figures II.5-II.8. Drug to nucleotide-phosphate concentration ratio
dependence on the efficiency of crosslinking for each of the N-sub
stituted azaadamantane isomers.
Data from Figures II.1-II.4 representing the time dependent
cross-
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Figure II. 5. Percent of crosslinked CT-DNA at specific
reaction
times as a function of the drug to nucleotide-phosphate
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Figure II. 6. Percent of crosslinked CT-DNA at specific reaction
times as a function of the drug to nucleotide-phosphate
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Figure II. 7. Percent of crosslinked CT-DNA at specific reaction
times as a function of the drug to nucleotide-phosphate
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Figure II. 8. Percent of crosslinked CT-DNA at specific reaction
times as a function of the drug to nucleotide-phosphate
concentration ratio for the 4,8-dichloro-N-piperdinoethyl
azaadamantane .
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As opposed to the 4,9 isomers, the percent of crosslink formation for
both of the 4,8 isomers appears to be stoichiometric up to a point
after which an increase is observed. For the 4,8 N-methyl isomer,
the percent of crosslink formation appears to be stoichiometric with
the drug to nucleotide-phosphate concentration ratio up to a ratio of
about 2.5, after which a large increase is observed until reaching a
ratio of approximately 3. A leveling off is then observed, probably
due to the saturation of available DNA binding sites. For the 4,8
N-piperdinoethyl isomer, the percent of crosslinking appears stoi
chiometric with the drug to nucleotide-phosphate concentration ratio
up to a ratio of approximately 1.5, after which a leveling off is
observed, again, probably due to a saturation of the available DNA
binding sites. An increase in the percent of crosslinking is then
observed after a ratio of approximately 4.5. Thses results would
suggest a possible cooperative behavior and/or the involvement of
more than one binding site for both of the 4,8 isomers. And, since
similar results were not observed for either of the 4,9 isomers, this
behavior can be attributed to the differences in stereochemistry
and/or the differences in the distance between alkylating centers
between the 4,8 and 4,9 isomers.
To note the possible effect of the different stereochemistry of
the isomers on the efficiency of crosslinking, comparisons were made
of the reaction profiles of the 4,8 and 4,9 isomers of the same
series at identical starting drug to nucleotide-phosphate concen
tration ratios. Figures II.9-II.il show the reaction profiles for
the N-methyl isomers and mechlorethamine at three different drug to
nucleotide-phosphate concentration ratios. As shown, the 4,9
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Figures II.9-II.il. Comparisons of the efficiency of crosslinking by
the N-methyl azaadamantanes.
Data from Figures II. 1 and II. 2 representing the time dependent




































Figure II. 9. Time dependent crosslinking of CT-DNA by
mechlorethamine and the 4,8 and 4,9 N-methyl azaadamantanes
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Figure 11.10. Time dependent crosslinking of CT-DNA by
mechlorethamine and the 4,8 and 4,9 N-methyl azaadamantanes




















Figure 11.11. Time dependent crosslinking of CT-DNA by
mechlorethamine and the 4,8 and 4,9 N-methyl azaadamantanes
at a drug to nucleotide-phosphate concentration ratio of 7.08.
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N-methyl isomer crosslinks to a greater extent than does the 4,8
N-methyl isomer, and both crosslink to a lesser extent than does
mechlorethamine. Similarly, the initial rate of crosslink formation
is greater for the 4,9 N-methyl isomer than for the 4,8 N-methyl
isomer. However, the distinct loss of DNA crosslinks occurs sooner
for the 4,9 N-methyl isomer than for the 4,8 N-methyl isomer, with
this loss occurring for both isomers much sooner than for mechlor
ethamine. Figures II. 12-11. 14 show the reaction profiles for me
chlorethamine and the 4,8 and 4,9 N-piperdinoethyl isomers at three
identical starting drug to nucleotide-phosphate concentration ratios.
As shown, the 4,9 N-piperdinoethyl isomer crosslinks to a greater
extent than does the 4,8 N-piperdinoethyl isomer, and both isomers
crosslink to a lesser extent than does mechlorethamine. The ^,9
N-piperdinoethyl isomer also crosslinks at a higher initial rate than
does the 4,8 N-piperdinoethyl isomer ; and begins to show a loss of
crosslinks sooner than does the 4,8 N-piperdinoethyl isomer. Both of
the N-piperdinoethyl isomers exhibit a loss of crosslinks sooner than
does mechlorethamine.
In order to note the possible effect of varying the nitrogen
substituent on the efficiency of crosslinking, comparisons were made
of the reaction profiles of the same isomers between the two series
at identical starting drug to nucleotide-phosphate concentration
ratios. As shown in Figures 11.15 and 11.16 for the N-methyl and
N-piperdinoethyl 4,8 isomers, the 4,8 N-piperdinoethyl isomer cross
links to a greater extent than does the 4,8 N-methyl isomer, and the
4,8 N-methyl isomer shows a loss of crosslinks sooner than does the
4,8 N-piperdinoethyl isomer. Similarly, as shown in Figures
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Figures II. 12-11. 14. Comparisons of the efficiency of crosslinking
by the N-piperdinoethyl azaadamantanes.
Data from Figures II. 3 and II. 4 representing the time dependent
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Figure II. 12. Time dependent crosslinking of CT-DNA by
mechlorethamine and the 4,8 and 4,9 N-piperdinoethyl
azaadamantanes at a drug to nucleotide-phosphate






















Figure 11.13. Time dependent crosslinking of CT-DNA by
mechlorethamine and the 4,8 and 4,9 N-piperdinoethyl
azaadamantanes at a drug to nucleotide-phosphate
concentration ratio of 4.25.
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Figure 11.14. Time dependent crosslinking of CT-DNA by
mechlorethamine and the 4,8 and 4,9 N-piperdinoethyl
azaadamantanes at a drug to nucleotide-phosphate
concentration ratio of 7.08.
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Figures 11.15 and 11.16. Comparisons of the efficiency of
cross-
linking by the 4,8 N-methyl and N-piperdinoethyl azaadamantanes.
Data from Figures II. 1 arid II. 3 representing the time dependent
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Figure 11.15. Time dependent crosslinking of CT-DNA by the
4,8 N-methyl and 4,8 N-piperdinoethyl
azaadamantanes at a drug
to nucleotide-phosphate
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Figure 11.16. Time dependent crosslinking of CT-DNA by the
4,8 N-methyl and 4,8 N-piperdinoethyl azaadamantanes at a drug
to nucleotide-phosphate concentration ratio of 7.08.
11.17 and 11.18 for the N-methyl and N-piperdinoethyl 4,9 isomers,
the 4,9 N-piperdinoethyl isomer crosslinks to a greater extent than
does the 4,9 N-methyl isomer, and the 4,9 N-methyl isomer exhibits a
loss of crosslinks sooner than does the 4,9 N-piperdinoethyl isomer.
SUMMARY AND CONCLUSIONS
The maximum extent of crosslinking, the reaction time at which
this maximum extent occurs and the initial rate of crosslink forma
tion for each of the azaadamantane isomers studied at the various
drug to nucleotide-phosphate concentration ratios used are summarized
in Tables II. 1 and II. 2 for the N-methyl and N-piperdinoethyl series
of isomers, respectively.
As shown, for both the N-methyl and N-piperdinoethyl series of
azaadamantanes, all of the compounds crosslinked to a lesser extent
than did mechlorethamine. This decreased efficiency of crosslink
formation may be due to the decreased aqueous solution stability of
the azaadamantanes leading to the formation of inactive crosslinking
species before interaction with the available DNA, to possible steric
hinderances due to the bulk of the adamantyl framework, or to pos
sible decreased stability of the induced crosslinks themselves as a
result of increased strain on the crosslinking bonds due to the fixed
distance between alkylating centers for the azaadamantanes as com
pared to the relative freedom of rotation allowed for mechlorethamine
to form more stable crosslinks.
Additionally, there are differences in crosslinking behavior for
both between and within the two N-substituted series of the
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Figures 11.17 and 11.18. Comparison of the efficiency of
cross-
linking by the 4,9 N-methyl and 4,9 N-piperdinoethyl azaadamantanes.
Data from Figures II. 2 and II. 4 representing the time dependent
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Figure 11.17. Time dependent crosslinking of CT-DNA by the
























% CROSSLINKING BY 4.9-METHYL AND
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-Figure 11.18. Time dependent crosslinking of CT-DNA by the
4,9 N-methyl and &,9 N-piperdinoethyl azaadamantanes at a drug
to nucleotide-phosphate concentration ratio of 7.08.
4,8 N-methyl iscner 4,9 ^hTethy.L Isomer
ryp t(n_x) max % initial rate t(max) max % initial rate
I_ttio (min.) x-link (%/min.) (min.) x-link (%/min.)
1.82 9 5 1.3 3.7 24 15.8
2.42 9 10 2.6 3.7 33 18.6
3.03 9 18 7.5 4 41 22.4
4.25 8 23 8.4 4.1 43 30.5
5.66 9.8 27 11.3 4.8 45 32.8
7.08 9 28 15.0 4.7 50 35.9
Table II. 2. Time dependent crosslinking summary
for the N-methyl azaadamantane isomers.
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4,8 N-pirsrdincethyl Isomer 4,9 N-pipanr_JTcet_7/l Isorer
D/P t(max) max % initial rate t(max) max % initial rate
Ratio (min.) x-link (%/min.) (min.) x-link (%/min.)
1.82 31 24 2.8 7.8 27 12.9
4.25 25 32 6.6 8.3 55 32.1
7.03 30 54 7.7 8 65 48.0
Table II. 3 Time dependent crosslinking summary
for the N-piperdinoethyl azaadamantane isomers.
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azaadamantane isomers. That is, at identical starting drug to
nucleotide-phosphate concentration ratios, the 4,9 isomers crosslink
to a greater extent than do their corresponding 4,8 isomers within
the same series and the 4,8 and 4,9 N-piperdinoethyl isomers cross
link to greater extents than do the 4,8 and 4,9 N-methyl isomers,
respectively.
The increased crosslinking by the 4,9 isomers within the same
series is in contrast as to what may be expected from the aqueous
solution stability results, since the 4,9 isomers of both series are
less stable than the corresponding 4,8 isomers of the same series
suggesting that the 4,9 isomers may undergo more rapid hydrolysis
than the 4,8 isomers to yield inactive crosslinking species. How
ever, these results may suggest that the decreased aqueous solution
stability of the 4,9 isomers could lead to increasingly reactive
intermediates followed by increased DNA crosslink formation. More
simply, these results may be directly due to the intrinsic stereoche
mical differences between the two isomers and have very little to do
with the differences in the aqueous solution stabilities between the
two isomers within the same series.
The increased crosslinking by the 4,8 and 4,9 N-piperdinoethyl
isomers as compared to the 4,8 and 4,9 N-methyl isomers,
respectively, may be due to some intrinsic differences in the two
different nitrogen substituent interactions with the DNA. This would
seem most likely, since unlike the case of the less stable 4,9
isomers crosslinking to greater extents than the corresponding more
stable 4,8 isomers within the same series, the more stable
N-piperdinoethyl isomers crosslink to greater extents than do the
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corresponding N-methyl isomers. Similarly, since the 4,8 N-methyl
isomer and the 4,9 N-piperdinoethyl isomer have similar aqueous
solution half-lifes of 5.4 minutes and 5.55 minutes, respectively,
the increased
crosslinking by the 4,9 N-piperdinoethyl isomer would
indicate that the stereochemical and/or nitrogen substituent
interactions, as well as the possible aqueous solution stability
factors, must be taken into consideration.
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CHAPTER III
STABILITY OF AZAADAMANTANE INDUCED CROSSLINKS
INTRODUCTION
Figures II. 1, II. 2 and II. 4 of Chapter II show a significant
loss of existing crosslinks at extended reaction times for the 4,8
N-methyl, 4,9 N-methyl and 4,9 N-piperdinoethyl azaadamantane iso
mers, respectively. As shown in Figures III. I and III. 2, a similar
loss of existing crosslinks is also seen for the 4,8 N-piperdinoethyl
isomer as well as for mechlorethamine, which exhibits this loss of
existing crosslinks at much longer reaction times than those for the
azaadamantane isomers.
There are a number of known mechanisms of action which could
possibly lead to this observed loss of existing DNA interstrand
crosslinks. A number of known DNA crosslinking agents show a loss of
crosslinks as a result of DNA strand breakage. Treatment of DNA with
l-(2-chloroethyl)-l-nitrosoureas and certain aryltriazenes, for
example, have led to DNA strand scission due to alkylation of the DNA
phosphates, rendering the resulting
phosphotriester susceptible to
rapid basic hydrolysis leading to DNA strand breakage (Lown, 1982).
Similarly, a slower DNA strand scission by other alkylating agents as
a result of base alkylation followed by depurination or
depyrimidi-
nation and subsequent facile base hydrolysis (Lown, 1982). Agents
such as dimethyl sulfate, which are known to preferentially alkylate
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Figures III.l and III. 2. Time dependent crosslinking reaction
profiles -for the 4,8 N-piperdinoethyl azaadamantane and mechlor
ethamine at extended reaction times.
us
The figures represent the time dependent crosslinking of Calf-Thym
DNA (Type 1, polymeric) by the 4,8 N-piperdinoethyl azaadamantane
isomer and mechlorethamine at drug to nucleotide-phosphate concen
tration ratios of 4.25 and 1, respectively. The reactions were
performed as described in Chapter II.
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Figure III.l. Time dependent crosslinking of CT-DNA by the
4,8-dichloro-N-piperdinoethyl azaadamantane at a drug to
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Figure III. 2. Time dependent crosslinking
of CT-DNA by
mechlorethamine at a drug to
nucleotide-phosphate
concentration ratio of 1.
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at the N7 of guanine have been shown to render the alkylated DNA
unstable at neutral pH and 37C yielding 7-alkyguanines due to
acid
catalyzed hydrolysis followed by DNA strand scission (Lawley, 1966) .
Studies with mechlorethamine (HN2) have indicated that the agent
preferentially reacts with the N7 of guanines to form the resulting
DNA interstrand crosslinks (Kallama and Hemminki, 1984). As with
dimethyl sulfate, evidence indicates that the guanine N7 alkylations
by HN2 also result in depurination followed by DNA strand breakage at
neutral pH, with the rate of depurination increasing with increased
temperature (Brookes and Lawley, 1961). However, under alkaline
conditions, N7 guanine alkylations have been shown to be stable due
to alkaline induced imadizole ring opening of the alkylated guanines
rather than depurination (Lown, 1982) .
Since the sites of alkylation for the azaadamantane isomers are
presently unknown, it is possible that the induced azaadamantane
crosslinks are unstable at the high alkaline pH of the ethidium
bromide assay solution (11.4). Similarly, since the crosslinked DNA
is heat denatured at this high alkaline pH, it is also possible that
the azaadamantane, as well as the HN2, induced crosslinks are heat
liable in alkali. Therefore, it was deemed necessary to test for the
possible heat liability of the induced crosslinks at the high alka
line pH of the standard ethidium bromide assay solution.
The heat liability of the azaadamantane and mechlorethamine
induced crosslinks at the high alkaline pH of the standard ethidium
bromide assay solution (11.4) will be tested for by using a modifi
cation of the general assay procedure. The
crosslinked DNA will be
exposed to dilute NaOH in excess of 0.05 N, which will denature the
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duplex structure of the DNA. The crosslinked DNA will then be
renatured by neutralization of the excess hydroxide by acid. This
method thereby eliminates the need for exposing the crosslinked DNA
to heat for denaturation which could effect heat liable crosslinks.
Identical reaction samples will also be heat denatured to allow for a
direct comparison of the resulting crosslinking reaction profiles.
EXPERIMENTAL
A. Materials and Methods:
The crosslinking agents, CT-DNA solution, standard ethidium
bromide assay solution and the general crosslink assay procedure were
all as outlined in Chapter I.
All reactions were performed in vitro at the physiological
conditions of pH=7, 37C and 0.15 M NaCl. The reaction concentration
of the CT-DNA was held constant at 0.15 mM in nucleotide-phosphate,
and the extent of crosslinking was measured as a function of time for
the 4,8 N-methyl isomer and mechlorethamine.
B. Determination of Alkaline Denaturation Conditions:
In order to insure that the alkaline denaturation step was
resulting in complete denaturation of the CT-DNA, a
30 yl aliquot of
the CT-DNA at the reaction concentration of 0.15 mM in
nucleotide-
phosphate was added to 1 ml of standard ethidium bromide assay
solution, and various amounts of 0.197 N NaOH were added for varying
amounts of time. The fluorescence of the samples was then compared
to the fluorescence of a sample, prepared as above, which underwent
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normal heat denaturation. Results indicated that exposure of the
CT-DNA to a 150 yl addition of the 0.197 N NaOH for 1 minute was
sufficient for complete denaturation. Further testing indicated that
a 135 yl addition of 0.197 HC1 was sufficient to return the reaction
sample to the pH of the standard ethidium bromide assay solution
(11.4). Therefore, reaction samples will be exposed to 150 yl
additions of 0.197 N NaOH and allowed to stand for 1 minute, after
which a 135 yl addition of 0.197 N HC1 will be used to return the
samples to the pH of the standard ethidium bromide assay solution,
thereby stopping the denaturation process.
C. Determination of the Extent of DNA Degradation Due to Hydrolysis:
Since the modification used will employ alkaline denaturation of
the crosslinked DNA, it was necessary to determine the extent of DNA
degradation due to alkaline hydrolysis. Therefore, a crosslinking
reaction with mechlorethamine at a drug to nucleotide-phosphate
concentration ratio of 1 was performed as described in Chapter II.
The reaction was allowed to continue until, according to previous
results, the maximum extent of crosslinking was achieved, approxi
mately 90 minutes. Two
30 yl aliquots of the reaction mixture were
then separately added to 1 ml
of standard ethidium bromide assay
solution. The extent of crosslinking was then measured by employing
the normal heat denaturation method for one sample and the alkaline
denaturation method for the other sample. Results indicated
tha-
approximately 15 percent
of the DNA present in the alkaline denatured
sample was lost due to alkaline hydrolysis.
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D. Modification of the General Assay Procedure to Determine Heat
Liability of the Induced DNA Crosslinks in the Standard Ethidium
Bromide Solution.
A 0.25 to 1 mg. sample of the crosslinking agents contained in a
microcapsule was added to 0.25 to 20 ml of 20 mM sodium phosphate at
pH=7 containing 0.15 M NaCl which would result in an equal volume
dilution with the CT-DNA at 0.30 mM in nucleotide-phosphate to give
the desired drug to nucleotide-phosphate concentration ratio.
Reactions were performed for mechlorethamine and the 4,8 N-methyl
isomer at drug to nucleotide-phosphate concentration ratios of 2 and
10, respectively. It is important to note that the drug to nucleo
tide-phosphate concentration ratio used for the 4,8 N-methyl azaada
mantane was not corrected for the aqueous solution stability, but was
based on the initial weight of the crosslinking agent. The
cross-
linking agents were then pre-dissolved in the calculated volume of
buffer for 3 minutes, after which the equal volume dilution with 0.30
mM nucleotide-phosphate CT-DNA was made, and the reactions initiated
at t=t . At specific reaction times, two 30 yl aliquots of the
reaction mixture were separately added to 1 ml of standard ethidium
bromide assay solution. One of the
duplicate samples for each of the
reaction times was assayed by the normal heat denaturation technique
as described in Chapters I and II.
The other set of duplicate samples was treated in the same
manner except for substitution of the heat denaturation technique
with the alkaline denaturation modification. Each of the samples
was exposed to a 150 yl addition of 0.197 N NaOH and allowed to stand
for 1 minute, after which a 135 yl addition of 0.197 N HC1 was made
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to return the pH to the pH of the standard ethidium bromide assay
solution.
Because of the dilution factors involved with the alkaline
denatured samples, it was necessary to provide separate control
samples to measure both the maximum expected fluorescence and the
fluorescence of the denatured, uncrosslinked DNA. Therefore, 30 yl
of 0.15 mM nucleotide-phosphate CT-DNA was added to 1 ml of standard
ethidium bromide assay solution and exposed to a 150 yl addition of
0.197 N NaOH for 1 minute, after which 135 yl of 0.197 N HC1 was
added to serve as a measure of the background fluorescence of ethidi
um bromide in the prescence of single-stranded DNA. Similarly, 150
yl of NaOH and 135 yl of HC1 were added to 1 ml of standard ethidium
bromide assay solution, after which 30 yl of 0.15 mM nucleotide-phos
phate CT-DNA was added to serve as a measure of the maximum expected
fluorescence.
The percent of crosslinked DNA was then determined for each of
the series of samples, as previously described, and plotted as a
function of the reaction time.
RESULTS AND DISCUSSION
For both the 4,8 N-methyl and mechlorethamine reactions, a 15
percent decrease in the maximum extent of crosslinking was observed
as determined by the heat denatured samples. This decrease was
attributed to the loss of 15 percent of the total DNA as a result of
alkaline hydrolysis and was therefore corrected for by adding 15
percent to each of the measured percent of crosslinked DNA values
110
obtained by the alkaline denaturation technique.
As shown in Figure III. 3 and III. 4 for mechlorethamine and the
4,8 N-methyl isomer, respectively, after correction for the 15
percent loss of DNA due to alkaline hydrolysis, there appears to be
no difference, within experimental error, in the measured extent of
crosslinking between the two methods. More importantly, both of the
methods employed show a loss of existing crosslinks for both of the
crosslinking agents at extended reaction times. These results would
suggest that the loss of the existing DNA interstrand crosslinks
previously observed by the heat denaturation technique are not the
result of heat liability of the induced crosslinks at the high
alkaline pH of the standard ethidium bromide assay solution (11.4).
SUMMARY AND CONCLUSIONS
As previously stated, the results indicate that the loss of the
induced DNA interstrand crosslinks by mechlorethamine and the 4,8
N-methyl isomer are not the result of heat liability of the
crosslinks at the high alkaline pH of the standard ethidium bromide
assay solution. However, due to
the intrinsic differences between
the 4,8 and 4,9 azaadamantane isomers, it would be expected that the
two isomers would alkylate at different specific sites on the DNA
molecule. This would suggest that the two crosslinks by the two
isomers might have different characteristic properties and, even
though the 4,8 N-methyl isomer induced crosslinks are not heat liable
at the high alkaline pH of the standard ethidium bromide assay
solution, the induced crosslinks by the 4,9 isomers may be.
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Figures 3 and 4. Time Dependent Crosslinking Reaction Profiles
of Mechlorethamine and the 4,8 N-methyl Azaadamantane Isomer Using
Heat and Alkaline Denaturation.
The figures represent the time dependent crosslinking of Calf-Thymus
DNA (Type 1, polymeric) by mechlorethamine and the 4,8 N-methyl
azaadamantane isomer at the drug to nucleotide-phosphate
concentration ratios of 2 and 10, respectively. Reactions were
performed at
37
C in 20 mM sodium phosphate buffer at pH=7, 0.15
M NaCl containing 0.15 mM nucleotide-phosphate CT-DNA. Pre-weighed
samples of the crosslinking agents were predissolved in a sufficient
volume of buffer which would give the desired drug to
nucleotide-phosphate concentration ratios after an equal volume
dilution with the CT-DNA. The drug to nucleotide-phosphate
concentration ratio used for the 4,8 N-methyl azaadamantane was
uncorrected for the aqueous solution instability, and was based
on the initial weight of the crosslinking agent. The reactions
were then initiated by ir.ixing equal volumes of the drug and CT-DNA
solutions at twice the reaction concentrations. At specific reaction
times, two identical 30 ul. samples of the reaction mixture were
separately added to 1 ml. of
standard ethidium bromide assay
solution. The percent of crosslinked DNA by the heat denaturation
technique was determined as previously described in Chapters I
and II. The alkaline denatured samples were denatured by exposing
the crosslinked DNA in the assay solution to
150 ul. of 0.197 N
NaOH for 1 minute, after which the denaturation
was stopped by
the addition of 135 ul. of 0.197 N HCL to bring the pH back to
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the pH of the standard ethidium bromide assay solution. The percent




















Figure 3. Time Dependent crosslinking of CT-DNA by mechlorethamine
at a drug to nucleotide-phosphate concentration ratio of 2 using
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Figure 4. Time dependent crosslinking of CT-DNA by the 4,
8-dichloro-
N-methyl azaadamantane at a drug to nucleotide-phosphate concentration




Furthermore, since there appears to be no significant differen
ces in the resulting time dependent crosslinking reaction isotherms,
and assuming that the induced crosslinks by the 4,9 isomers are not
heat liable at the high alkaline pH of the standard ethidium bromide
assay solution, it can be assumed that the time dependent cross-
linking reaction isotherms obtained by the original heat denaturation
technique are correct.
In the case of mechlorethamine, both methods indicate a
half-
life for the loss of existing crosslinks of approximately 8 hours.
These results are in good agreement with previously published results
indicating the half-life to be approximately 7 hours (Ross, Ewig and
Kohn, 1978) . These previously published results were obtained by
exposure of mechlorethamine to L1210 cells and the loss of existing
crosslinks was attributed to enzymatic repair in vivo. However, the
in vitro loss of existing crosslinks in the absence of additional
cellular enzymes observed here suggest that the loss of exising
crosslinks previously observed was not due to enzymatic repair in
vivo, but rather due to the intrinsic instability of the mechloreth
amine induced crosslinks themselves.
The increased stability of the
mechlorethamine induced cross
links over the crosslinks induced by the 4,8 N-methyl isomer, as well
as the other azaadamantane isomers, may be due to a number of pos
sible reasons. Because of the freedom of rotation of the mechloreth
amine bonds as compared to the strict rigidity and the fixed distance
between alkylating centers of the azaadamantanes,
it is possible that
the covalent crosslinking bonds formed by
mechlorethamine are less
strained than those created by the azaadamantane isomers, thereby
increasing the stability of the formed interstrand crosslinks. It is
also possible that the large bulk of the adamantyl framework results
in some steric hinderance, again decreasing the stability of the
induced covalent crosslinking bonds.
The exact cause of the observed loss of existing DNA interstrand
crosslinks for the 4,8 N-methyl isomer, as well as the other azaada
mantane isomers, is, as yet, undetermined. A similar adamantyl
compound, N-(2-chloroethyl)-N'-(2-adamantyl)-N-nitrosourea has been
shown to crosslink DNA and induce depurination leading to DNA strand
scission (Lown et al, 1978) , and it may seem logical to assume that
the azaadamantane isomers studied here similarly lead to depurina
tion. It remains to be determined directly, however, whether the
observed less of the azaadamantane induced DNA crosslinks are indeed
the direct result of depurination or dep3/rimidination followed by
strand scission, induced strand scission without depurination or
depyrimidination, or simply a loss of the existing crosslinks without
damage to the DNA. To distinguish between these possible causes,
more research must be done to try to determine the exact site of DNA
alkylation for each of the azaadamantane isomers and to determine the
effects of this alkvlation on the DNA molecule itself.
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